NCT04639869View on ClinicalTrials.gov

Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 26, 2019

Primary Completion Date

July 26, 2019

Study Completion Date

August 27, 2019

Conditions
Bioequivalence
Interventions
DRUG

Phenyramydol HCl 400 mg Film Tablet

Phenyramydol HCL 400 mg Film Tablet contains 400 mg phenyramydol manufactured by Pharmactive Ilac.San ve Tic A.S

DRUG

Cabral 400 mg Film Tablet

Cabral 400 mg Film Tablet 400 mg phenyramydol manufactured by Recordati Ilac SAn ve Tic A.S.

Trial Locations (1)

06970

Novagenix Drug R&D Center, Akyurt

All Listed Sponsors
collaborator

Novagenix Bioanalytical Drug R&D Center

NETWORK

collaborator

Farmagen Ar-Ge Biyot. Ltd. Sti

NETWORK

lead

Humanis Saglık Anonim Sirketi

INDUSTRY

NCT04639869 - Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions | Biotech Hunter | Biotech Hunter